Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
biotech
boston blog main
7
×
boston top stories
cancer drugs
7
×
clinical trials
7
×
life sciences
national blog main
san francisco blog main
cancer
fda
national top stories
san francisco top stories
ipo
new york blog main
new york top stories
amgen
deals
investing
national
sanofi
acute myeloid leukemia
black diamond therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
colorectal cancer
detroit blog main
detroit top stories
eli lilly
europe blog main
glaxosmithkline
immunotherapy
indiana blog main
indiana top stories
loxo oncology
medical device
medicare
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
What
ipo
cancer
medicines
research
biotech
black
companies
disease
drug
hasn’t
new
pharmaceutical
proteins
revolution
roundup
targets
according
akcea
appetite
arrival
bio
bread
butter
buyout
cancer’s
cases
cash
centers
cigarettes
clinic
company’s
control
course
days
deaths
despite
development
diabetes
diamond
diamond’s
Language
unset
Current search:
photo
×
" clinical trials "
×
" cancer drugs "
×
" boston blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More